Label Changes for:
Etopophos (etoposide phosphate) powder for injection
Changes have been made to the WARNINGS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011
- Injection site reactions may occur during the administration of Etopophos. Closely monitor the infusion site for possible infiltration during drug administration. No specific treatment for extravasation reactions is known.
- Local soft tissue toxicity has been reported following extravasation of Etopophos.